KEYWORD INDEX
| |
|
|
|
|
|
Search results for: "O"
Results 1 - 10 of 89 shown below |
|
| obesity |
|
| Juan R Bustillo, John Lauriello, Katherine Parker, Roger Hammond, Laura Rowland, Michael Bogenschutz and Samuel Keith Treatment of Weight Gain with Fluoxetine in Olanzapine-Treated Schizophrenic Outpatients doi:10.1038/sj.npp.1300089 Neuropsychopharmacology 28, 527-529 | Abstract | Full text | PDF | |
|
| R D Levitan, M Masellis, R W Lam, P Muglia, V S Basile, U Jain, A S Kaplan, S Tharmalingam, S H Kennedy and J L Kennedy Childhood Inattention and Dysphoria and Adult Obesity Associated with the Dopamine D4 receptor Gene in Overeating Women with Seasonal Affective Disorder doi:10.1038/sj.npp.1300314 Neuropsychopharmacology 29, 179-186 | Abstract | Full text | PDF | |
|
| Dan W Haupt, Angela Luber, Justin Maeda, Angela K Melson, Julie A Schweiger and John W Newcomer Plasma Leptin and Adiposity During Antipsychotic Treatment of Schizophrenia doi:10.1038/sj.npp.1300563 Neuropsychopharmacology 30, 184-191 | Abstract | Full text | PDF | |
|
| Marcello Solinas and Steven R Goldberg Motivational Effects of Cannabinoids and Opioids on Food Reinforcement Depend on Simultaneous Activation of Cannabinoid and Opioid Systems doi:10.1038/sj.npp.1300720 Neuropsychopharmacology 30, 2035-2045 | Abstract | Full text | PDF | |
|
| Igor Elman, David Borsook and Scott E Lukas Food Intake and Reward Mechanisms in Patients with Schizophrenia: Implications for Metabolic Disturbances and Treatment with Second-Generation Antipsychotic Agents doi:10.1038/sj.npp.1301051 Neuropsychopharmacology aop, - | |
|
| Murray A Raskind, Brianna L Burke, Norman J Crites, Andre M Tapp and Dennis D Rasmussen Olanzapine-Induced Weight Gain and Increased Visceral Adiposity is Blocked by Melatonin Replacement Therapy in Rats doi:10.1038/sj.npp.1301093 Neuropsychopharmacology 32, 284-288 | Abstract | Full text | PDF | |
|
| object recognition task |
|
Cindy K J Lieben, Arjan Blokland, Ayhan ![]() k, Eric Sung, Petra van Nieuwenhuizen and Rudy SchreiberThe Selective 5-HT6 Receptor Antagonist Ro4368554 Restores Memory Performance in Cholinergic and Serotonergic Models of Memory Deficiency in the Rat doi:10.1038/sj.npp.1300777 Neuropsychopharmacology 30, 2169-2179 | Abstract | Full text | PDF | |
|
| Obsessive compulsive disorder |
|
| Herbert Meltzer, Bijan Bastani, Karuna Jayathilake and Michael Maes Fluoxetine, but not Tricyclic Antidepressants, Potentiates the 5-Hydroxytryptophan-Mediated Increase in Plasma Cortisol and Prolactin Secretion in Subjects with Major Depression or with Obsessive Compulsive Disorder doi:10.1016/S0893-133X(96)00280-1 Neuropsychopharmacology 17, 1-11 | Abstract | PDF | |
|
| Obsessive compulsive disorder (OCD) |
|
| Diana L Martinez and Mark A Geyer Characterization of the Disruptions of Prepulse Inhibition and Habituation of Startle Induced by -Ethyltryptaminedoi:10.1016/S0893-133X(96)00240-0 Neuropsychopharmacology 16, 246-255 | Abstract | PDF | |
|
| obsessive–compulsive behaviors |
|
| Eric Hollander, Sherie Novotny, Margaret Hanratty, Rona Yaffe, Concetta M DeCaria, Bonnie R Aronowitz and Serge Mosovich Oxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders doi:10.1038/sj.npp.1300021 Neuropsychopharmacology 28, 193-198 | Abstract | Full text | PDF | |
|
| Obsessive-compulsive disorder |
|
| Gerard J Marek, Linda L Carpenter, Christopher J McDougle and Lawrence H Price Synergistic Action of 5-HT2A Antagonists and Selective Serotonin Reuptake Inhibitors in Neuropsychiatric Disorders doi:10.1038/sj.npp.1300057 Neuropsychopharmacology 28, 402-412 | Abstract | Full text | PDF | |
|
| Peter A Tass, Joachim Klosterkötter, Frank Schneider, Doris Lenartz, Anastasios Koulousakis and Volker Sturm Obsessive-Compulsive Disorder: Development of Demand-Controlled Deep Brain Stimulation with Methods from Stochastic Phase Resetting doi:10.1038/sj.npp.1300144 Neuropsychopharmacology 28, S27-S34 | Abstract | Full text | PDF | |
|
| Philip R Szeszko, Shauna MacMillan, Marjorie McMeniman, Elisa Lorch, Rachel Madden, Jennifer Ivey, S Preeya Banerjee, Gregory J Moore and David R Rosenberg Amygdala Volume Reductions in Pediatric Patients with Obsessive–Compulsive Disorder Treated with Paroxetine: Preliminary Findings doi:10.1038/sj.npp.1300399 Neuropsychopharmacology 29, 826-832 | Abstract | Full text | PDF | |
|
| Robert M Bilder, Jan Volavka, Herbert M Lachman and Anthony A Grace The Catechol-O-Methyltransferase Polymorphism: Relations to the Tonic–Phasic Dopamine Hypothesis and Neuropsychiatric Phenotypes doi:10.1038/sj.npp.1300542 Neuropsychopharmacology 29, 1943-1961 | Abstract | Full text | PDF | |
|
| Mostafa El Mansari, Claude Bouchard and Pierre Blier Alteration of Serotonin Release in the Guinea Pig Orbito-Frontal Cortex by Selective Serotonin Reuptake Inhibitors doi:10.1016/0893-133X(95)00045-F Neuropsychopharmacology 13, 117-127 | Abstract | PDF | |
|
| Allen R Braun, Christopher Randolph, Brigitte Stoetter, Erich Mohr, Christine Cox, Katalin Vladar, Roy Sexton, Richard E Carson, Peter Herscovitch and Thomas N Chase The Functional Neuroanatomy of Tourette's Syndrome: An FDG-PET Study. II: Relationships between Regional Cerebral Metabolism and Associated Behavioral and Cognitive Features of the Illness doi:10.1016/0893-133X(95)00052-F Neuropsychopharmacology 13, 151-168 | Abstract | PDF | |
|
| David Michelson, Margaret Altemus, Elise Galliven, Lauren Hill, Benjamin D Greenberg and Philip Gold Naloxone-Induced Pituitary-Adrenal Activation Does Not Differ in Patients with Depression, Obsessive Compulsive Disorder, and Healthy Controls doi:10.1016/0893-133X(95)00210-5 Neuropsychopharmacology 15, 207-212 | PDF | |
|
| Gregory L Hanna, Joseph A Himle, George C Curtis, Diane Q Koram, Jeremy Veenstra-Vander Weele, Bennett L Leventhal and Edwin H Cook Serotonin Transporter and Seasonal Variation in Blood Serotonin in Families with Obsessive-Compulsive Disorder doi:10.1016/S0893-133X(97)00097-3 Neuropsychopharmacology 18, 102-111 | Abstract | PDF | |
|
| Stefano Erzegovesi, Livia Martucci, Marta Henin and Laura Bellodi Low versus Standard Dose mCPP Challenge in Obsessive-Compulsive Patients doi:10.1016/S0893-133X(00)00178-0 Neuropsychopharmacology 24, 31-36 | Abstract | Full text | PDF | |
|
| Obsessive-compulsive disorder (OCD) |
|
| Daphna Joel and Julia Doljansky Selective Alleviation of Compulsive Lever-Pressing in Rats by D1, but not D2, Blockade: Possible Implications for the Involvement of D1 Receptors in Obsessive–Compulsive Disorder doi:10.1038/sj.npp.1300010 Neuropsychopharmacology 28, 77-85 | Abstract | Full text | PDF | |
|
| Sanjaya Saxena, Arthur L Brody, Karron M Maidment, Jennifer J Dunkin, Mark Colgan, Shervin Alborzian, Michael E Phelps and Lewis R Baxter Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder doi:10.1016/S0893-133X(99)00082-2 Neuropsychopharmacology 21, 683-693 | Abstract | Full text | PDF | |
|
| Occasion setter |
|
| Friedbert Weiss, Remi Martin-Fardon, Roberto Ciccocioppo, Tony M Kerr, Diana L Smith and Osnat Ben-Shahar Enduring Resistance to Extinction of Cocaine-Seeking Behavior Induced by Drug-Related Cues doi:10.1016/S0893-133X(01)00238-X Neuropsychopharmacology 25, 361-372 | Abstract | Full text | PDF | |
|
| Occasion setting |
|
| Hans S Crombag, Jeffrey W Grimm and Yavin Shaham Effect of Dopamine Receptor Antagonists on Renewal of Cocaine Seeking by Reexposure to Drug-associated Contextual Cues doi:10.1016/S0893-133X(02)00356-1 Neuropsychopharmacology 27, 1006-1015 | Abstract | Full text | PDF | |
|
| Occasion-setting |
|
| Stephan G Anagnostaras, Timothy Schallert and Terry E Robinson Memory Processes Governing Amphetamine-induced Psychomotor Sensitization doi:10.1016/S0893-133X(01)00402-X Neuropsychopharmacology 26, 703-715 | Abstract | Full text | PDF | |
|
| Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
|
Next |
| top |
|


k, Eric Sung, Petra van Nieuwenhuizen and Rudy Schreiber
-Ethyltryptamine
